506U78 in Treating Patients With Lymphoma

Summary

Phase II trial to study the effectiveness of 506U78 in treating patients who have lymphoma that has not been treated previously or that has not responded to previous treatment. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die

Timeline

Start

2000-05

Primary completion

2006-01

Completion

—

Drugs

Indications